 Leverkusen, Germany, May 06, 2021 GLOBE NEWSWIRE -- Biofrontera AG NASDAQ: BFRA; Frankfurt Stock Exchange: B8F the Company, an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of April 2021. 